Real-world adherence to toxicity management guidelines for immune checkpoint inhibitor-induced diabetes mellitus

OBJECTIVE: Immune checkpoint inhibitors(ICIs) have improved survival and are increasingly used for cancer. However, ICIs use may be limited by immune-related adverse events (irAEs), such as ICI-induced diabetes mellitus(ICI-DM). The objective of the present study was to characterize ICI-DM patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Min, Chen, Doudou, Zhao, Ruiling, Zheng, Xuqin, Gu, Yong, Yang, Tao, Shi, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405819/
https://www.ncbi.nlm.nih.gov/pubmed/37554766
http://dx.doi.org/10.3389/fendo.2023.1213225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405819/
https://www.ncbi.nlm.nih.gov/pubmed/37554766
http://dx.doi.org/10.3389/fendo.2023.1213225

Ejemplares similares